FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of Ventricular Tachycardia (LESS-VT) Study
ClinicalTrials.gov NCT03490201
Research payments
$980,908
Through program year 2020, $980,908 in research payments was reported against FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of Ventricular Tachycardia (LESS-VT) Study, across 147 payments, paid by Abbott Laboratories.
- Paid by
- Abbott Laboratories
- ClinicalTrials.gov
- NCT03490201
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $980,908 | 147 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Jeffrey Winterfield Mt Pleasant, SC Named on 14 payments
- Ramesh Hariharan Houston, TX Named on 11 payments
- Melissa Robinson Seattle, WA Named on 11 payments
- Daniel Benhayon Lanes Hollywood, FL Named on 10 payments
- Anshul Patel Atlanta, GA Named on 9 payments
- John Burkhardt Austin, TX Named on 9 payments
- Harikrishna Tandri Baltimore, MD Named on 8 payments
- Nilesh Mathuria Katy, TX Named on 8 payments
- David Frankel Philadelphia, PA Named on 7 payments
- Bengt Herweg Tampa, FL Named on 7 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.